Skip to main content

Essential Thrombocythemia

  • Chapter
  • First Online:
Consults in Obstetric Anesthesiology
  • 100 Accesses

Abstract

Essential thrombocythemia (ET) is an acquired, Philadelphia chromosome-negative myeloproliferative neoplasm (MPN) that is characterized by a sustained elevation in platelet count (greater than 450 G/l on two occasions). Parturients with ET are at risk of hemorrhagic and, more commonly, thromboembolic events. If anticoagulated, the timing of neuraxial block will need to occur within a safe window. Early delivery planning with a multidisciplinary care team is, therefore, prudent and may prevent the need for an alternative to neuraxial analgesia/anesthesia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Valera M-C, Parant O, Vayssiere C, Arnal J-F, Payrastre B. Essential thrombocythemia and pregnancy. Eur J Obstet Gynecol Reprod Biol. 2011;158(2):141–7.

    Article  Google Scholar 

  2. Chow EY, Haley LP, Vickars LM. Essential thrombocythemia in pregnancy: platelet count and pregnancy outcome. Am J Hematol. 1992;41(4):249–51.

    Article  CAS  Google Scholar 

  3. Villani M, Colaizzo D, Tiscia GL, Chinni E, Bodenizza C, Cascavilla N, et al. Postpartum haemorrhage in a woman with essential thrombocythemia carrying calreticulin mutation. Blood Coagul Fibrinolysis. 2016;27(6):727–8.

    Article  Google Scholar 

  4. Randi ML, Bertozzi I, Rumi E, Elena C, Finazzi G, Vianelli N, et al. Pregnancy complications predict thrombotic events in young women with essential thrombocythemia. Am J Hematol. 2014;89(3):306–9.

    Article  Google Scholar 

  5. Harrison C. Pregnancy and its management in the Philadelphia negative myeloproliferative diseases. Br J Haematol. 2005;129(3):293–306.

    Article  CAS  Google Scholar 

  6. Onisai M, Voican I, Ciorascu M, Popov V, Bumbea H, Gaman M, et al. Early severe preeclampsia with marked platelet dysfunction in association with essential thrombocytemia. Blood Coagul Fibrinolysis. 2015;26(7):830–7.

    Article  Google Scholar 

  7. Alimam S, Bewley S, Chappell LC, Knight M, Seed P, Gray G, et al. Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study. Br J Haematol. 2016;175(1):31–6.

    Article  Google Scholar 

  8. Griesshammer M, Struve S, Barbui T. Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy. Blood Rev. 2008;22:235–45.

    Article  Google Scholar 

  9. Finazzi G. How to manage essential thrombocythemia. Leukemia. 2011;26:875–82.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jaime Aaronson M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Aaronson, J. (2018). Essential Thrombocythemia. In: Mankowitz, S. (eds) Consults in Obstetric Anesthesiology. Springer, Cham. https://doi.org/10.1007/978-3-319-59680-8_53

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59680-8_53

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-59679-2

  • Online ISBN: 978-3-319-59680-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics